Concepedia

Chengbi Xu

CX

Statistics

Publications

8

Citations

176

H-Index

8

Active since

2018

Affiliations

Second Affiliated Hospital of Jilin University(Current)

Jilin University

First Hospital of Jilin University

Chengbi Xu is an author at Second Affiliated Hospital of Jilin University specializing in oncology, life sciences, and molecular oncology.

ORCID

Publications per year

2018–2021

8

Publications

8

Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206

Kai Xue, Jinqiu Li, Shanji Nan et al. · Life Sciences · 2019 · 45 citations · Full text

, , +14

MicroRNA-129-5p suppresses nasopharyngeal carcinoma lymphangiogenesis and lymph node metastasis by targeting ZIC2

Dan Yu, Guanghong Han, Xue Zhao et al. · Cellular Oncology · 2019 · 37 citations · Full text

, , +14

Interfering microRNA-410 attenuates atherosclerosis via the HDAC1/KLF5/IKBα/NF-κB axis

Shanji Nan, Ying Wang, Chengbi Xu et al. · Molecular Therapy — Nucleic Acids · 2021 · 26 citations · Full text

, , +14

RORA Overexpression Alleviates Nasal Mucosal Injury and Enhances Red Blood Cell Immune Adhesion Function in a Mouse Model of Allergic Rhinitis via Inactivation of the Wnt/β-Catenin Signaling Pathway

Jinqiu Li, Kai Xue, Yan Zheng et al. · International Archives of Allergy and Immunology · 2019 · 23 citations

, , +17

Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration

Dan Yu, Jinzhang Cheng, Kai Xue et al. · Pathology & Oncology Research · 2018 · 13 citations

, , +16

1–5 of 8